X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ADCOCK INGRAM (S. Africa) - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN   ADCOCK INGRAM
EQUITY SHARE DATA
    LUPIN
Mar-18
ADCOCK INGRAM
Jun-14
LUPIN/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,465354-   
Low Rs727255-   
Sales per share (Unadj.) Rs349.6105.2-  
Earnings per share (Unadj.) Rs5.6-26.5-  
Cash flow per share (Unadj.) Rs29.6-22.0-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs300.382.6-  
Shares outstanding (eoy) m452.08168.78-   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.12.9 108.4%   
Avg P/E ratio x197.2-11.5 -1,717.4%  
P/CF ratio (eoy) x37.1-13.9 -267.4%  
Price / Book Value ratio x3.63.7 99.0%  
Dividend payout %90.00-   
Avg Mkt Cap Rs m495,50251,396 964.1%   
No. of employees `00017.04.3 397.0%   
Total wages/salary Rs m28,6473,226 888.1%   
Avg. sales/employee Rs Th9,273.64,137.7 224.1%   
Avg. wages/employee Rs Th1,681.0751.4 223.7%   
Avg. net profit/employee Rs Th147.4-1,042.6 -14.1%   
INCOME DATA
Net Sales Rs m158,04217,763 889.7%  
Other income Rs m1,504124 1,208.7%   
Total revenues Rs m159,54517,888 891.9%   
Gross profit Rs m31,475-3,078 -1,022.5%  
Depreciation Rs m10,859767 1,416.4%   
Interest Rs m2,044481 424.7%   
Profit before tax Rs m20,076-4,202 -477.8%   
Minority Interest Rs m-71-12 605.4%   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,885263 1,098.7%   
Profit after tax Rs m2,513-4,476 -56.1%  
Gross profit margin %19.9-17.3 -114.9%  
Effective tax rate %14.4-6.2 -229.9%   
Net profit margin %1.6-25.2 -6.3%  
BALANCE SHEET DATA
Current assets Rs m122,09513,010 938.5%   
Current liabilities Rs m50,9567,320 696.1%   
Net working cap to sales %45.032.0 140.5%  
Current ratio x2.41.8 134.8%  
Inventory Days Days85111 76.3%  
Debtors Days Days120124 96.8%  
Net fixed assets Rs m129,8767,584 1,712.6%   
Share capital Rs m90482 1,096.4%   
"Free" reserves Rs m134,8660-   
Net worth Rs m135,77113,942 973.8%   
Long term debt Rs m64,2454,900 1,311.3%   
Total assets Rs m263,05426,338 998.8%  
Interest coverage x10.8-7.7 -140.0%   
Debt to equity ratio x0.50.4 134.7%  
Sales to assets ratio x0.60.7 89.1%   
Return on assets %1.7-15.2 -11.4%  
Return on equity %1.9-32.1 -5.8%  
Return on capital %3.7-19.8 -18.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,8070-   
CASH FLOW
From Operations Rs m17,5121,516 1,155.0%  
From Investments Rs m-14,073-466 3,022.8%  
From Financial Activity Rs m-14,9214,447 -335.6%  
Net Cashflow Rs m-11,4825,497 -208.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.88 Rs / ZAR

Compare LUPIN With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare LUPIN With: AJANTA PHARMA  SUN PHARMA  PANACEA BIOTECH  UNICHEM LAB  AUROBINDO PHARMA  



Today's Market

US China Trade War Escalations and Election Results: Volatility Set to Rule(Podcast)

India could be the latest direct victim of the US-China trade war. The increasing escalations have already slowed down global growth.

Related Views On News

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

These Dividend Stocks Could Boost Your Returns Better Than You Can Imagine(Profit Hunter)

May 7, 2019

The art of dividend investing is a lot more than investing in companies with high dividend payouts or stocks with high dividend yields...

Limited Upside, Higher Downside(The Honest Truth)

May 6, 2019

The market's irrational reaction may present opportunities for a limited period of time.

3 Indian Stocks Replicating Amazon's Successful Strategy(The 5 Minute Wrapup)

May 10, 2019

The one critical element that has made Amazon a force to reckon with...

A Simple Checklist for Picking Great Dividend Stocks(Profit Hunter)

May 9, 2019

A filtered, neat list of high-dividend stocks with all this dirty work already done for you.

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


May 17, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS